Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Healthtrust
Cipla
Teva
Express Scripts
McKesson

Generated: May 24, 2019

DrugPatentWatch Database Preview

KEPIVANCE Drug Profile

« Back to Dashboard

Summary for Tradename: KEPIVANCE
Patents:40
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for KEPIVANCE

US Patents for KEPIVANCE

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biovitrum Ab KEPIVANCE palifermin INJECTABLE; INJECTION 125103 001 2004-12-15 ➤ Sign Up THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, NY) ➤ Sign Up RX search
Biovitrum Ab KEPIVANCE palifermin INJECTABLE; INJECTION 125103 001 2004-12-15 ➤ Sign Up Enzychem Lifesciences Corporation (Seoul, KR) ➤ Sign Up RX search
Biovitrum Ab KEPIVANCE palifermin INJECTABLE; INJECTION 125103 001 2004-12-15 ➤ Sign Up Innovation Pharmaceuticals Inc. (Beverly, MA) ➤ Sign Up RX search
Biovitrum Ab KEPIVANCE palifermin INJECTABLE; INJECTION 125103 001 2004-12-15 ➤ Sign Up Biosuccess Biotech Co. Ltd. (Santa Clara, CA) ➤ Sign Up RX search
Biovitrum Ab KEPIVANCE palifermin INJECTABLE; INJECTION 125103 001 2004-12-15 ➤ Sign Up SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for KEPIVANCE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
15/2006 Austria ➤ Sign Up PRODUCT NAME: PALIFERMIN; REGISTRATION NO/DATE: EU/1/05/314/001 20051025
SPC/GB06/015 United Kingdom ➤ Sign Up PRODUCT NAME: PALIFERMIN; REGISTERED: UK EU/1/05/314/001 20051025
SPC005/2006 Ireland ➤ Sign Up SPC005/2006: 20061023, EXPIRES: 20190427
C00706563/01 Switzerland ➤ Sign Up PRODUCT NAME: PALIFERMIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 57334 11.09.2006
SZ 15/2006 Austria ➤ Sign Up PRODUCT NAME: PALIFERMIN
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
UBS
Moodys
Cipla
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.